Notably, fibroblasts derived from IPF patients' lung also exhibited a higher level of SRPX2 than that from control subjects, along with markedly enhanced expressions of the fibrotic markers, COL1A1 and α-SMA (Figure 1C). The gene discussed is ACTA1; the disease is idiopathic pulmonary fibrosis.